Limited time75% off all plans
Get the app

Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance

On this page

AMR Basics - Resistance 101

  • Antimicrobial Resistance (AMR): A microbe's ability to withstand antimicrobial drugs, rendering treatments ineffective and infections persistent.
  • Resistance Categories:
    • MDR (Multidrug Resistance): Resistance to at least one agent in ≥3 antimicrobial categories.
    • XDR (Extensive Drug Resistance): Resistance to all but ≤2 antimicrobial categories.
    • PDR (Pandrug Resistance): Resistance to all agents in all antimicrobial categories.
  • Impact & Burden:
    • A critical global health security threat.
    • Leads to treatment failures, ↑ morbidity, mortality, and economic burden.
    • India carries a high burden of AMR.

⭐ Globally, MDR-TB is a major public health crisis, with India having one of the highest burdens of the disease and its drug-resistant forms.

Resistance Tricks - Bugs Fight Back

Bacteria evade antibiotics via:

  • Enzymatic Inactivation: e.g., β-lactamases cleave β-lactam drugs.
  • Target Site Modification:
    • Altered PBPs (e.g., PBP2a in MRSA) $\rightarrow$ ↓ β-lactam binding.
    • Altered D-Ala-D-Lac (VanA/VanB in VRE) $\rightarrow$ ↓ vancomycin binding.
    • rRNA methylation $\rightarrow$ ↓ macrolide/clindamycin binding.
  • Reduced Permeability: Porin loss (Gram-negatives) limits drug entry.
  • Active Efflux Pumps: Expel antibiotics from the cell.

Mechanisms of Antimicrobial Resistance

Genetic Basis:

  • Intrinsic: Natural, inherent resistance.
  • Acquired: New resistance via mutation or Horizontal Gene Transfer (HGT).

    ⭐ The most common mechanism of resistance to β-lactam antibiotics is the production of β-lactamase enzymes, which hydrolyze the β-lactam ring.

Horizontal Gene Transfer (HGT) Mechanisms: 📌 Mnemonic: Cats Try Treats (Conjugation, Transduction, Transformation)

📌 ESKAPE pathogens & others:

PathogenKey Resistance (Gene/Mechanism)Clinical Impact
Staphylococcus aureus (MRSA)mecAMethicillin-R; SSTI
Enterococcus faecium (VRE)vanA, vanBVancomycin-R; UTIs
Klebsiella pneumoniae (ESBL/CRE)CTX-M; NDM-1, KPC, OXA-48Carbapenem-R, HAIs
Acinetobacter baumannii (MDR)OXA-carbapenemasesMDR; VAP, HAIs
Pseudomonas aeruginosa (MDR)Metallo-β-lactamases (MBLs)MDR; HAIs, CF inf.
Enterobacter spp. (ESBL/CRE)CTX-M; NDM-1Carbapenem-R, HAIs
Mycobacterium tuberculosis (MDR/XDR)rpoB, katG; +FQ/SLIDifficult TB, ↑mortality

Lab Detectives - Finding Foes

  • Phenotypic Methods:
    • Disk diffusion (Kirby-Bauer): Zone sizes show susceptibility. Kirby-Bauer test showing zones of inhibition
    • MIC determination: Broth dilution, E-test (gradient).
    • Automated systems (e.g., VITEK).
    • Use CLSI/EUCAST breakpoints for interpretation.
  • Specific Phenotypic Tests:
    • D-test: For inducible clindamycin resistance (📌 D-shape zone).
    • MHT/Carba NP test: Detects carbapenemases.
  • Genotypic Methods:
    • PCR: For resistance genes (e.g., mecA, vanA, blaKPC, blaNDM, blaOXA-48).
    • Sequencing: For detailed genetic analysis.

⭐ The D-test is used to detect inducible clindamycin resistance in Staphylococcus aureus strains that appear erythromycin-resistant and clindamycin-susceptible in routine testing.

AMR Counterattack - Our Battle Plan

  • Antimicrobial Stewardship Programs (ASP): Optimize antibiotic use, ↓resistance, improve patient outcomes.

    ⭐ Key elements of Antimicrobial Stewardship Programs include prospective audit with intervention and feedback, and formulary restriction with preauthorization.

  • Infection Prevention & Control (IPC): Crucial measures include:
  • Additional Strategies: Promote rational drug use, invest in new drug R&D, explore combination therapies, and develop vaccines.
  • National Guidance: India's National Action Plan on AMR coordinates national efforts.

High‑Yield Points - ⚡ Biggest Takeaways

  • ESBLs confer resistance to penicillins, cephalosporins, monobactams; often plasmid-mediated.
  • MRSA due to mecA gene (altered PBP2a) resists most beta-lactams.
  • VRE via VanA/VanB genes alters peptidoglycan target (D-Ala-D-Lac) for vancomycin resistance.
  • Carbapenemases (e.g., KPC, NDM-1) hydrolyze carbapenems, causing broad beta-lactam resistance.
  • MDR-TB signifies resistance to at least isoniazid and rifampicin.
  • Key resistance mechanisms: enzymatic inactivation, target site modification, active efflux pumps.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE